Global Reach

China’s changing regulatory environment and increasingly competitive landscape require medical device companies to develop a localized strategy to enter the Chinese market. As China's leading medical device CRO (including IVD), our expertise and enriched project experiences can help our clients to navigate cultural differences, monitor regulatory changes, and marketize our clients’ products in the most efficient and cost-effective way. Since 2000, we have collaborated with top 20 global medical device companies and worked with more than 600 clients overseas to successfully launch their products in China. Globally, Tigermed-Jyton have established long-term cooperation with more than 1900 medical device R&D and manufacturing enterprises from more than 30 countries, and have set up more than 180 global offices worldwide. With our SOPs and QMS complying with global standards, we offer regulatory affairs and clinical trial services in all major markets. We have global teams of specialists and professionals expertizing in local regulations. With a solid team based in China, Tigermed-Jyton has cost advantages, offering top-tier services such as global study clinical operation, data management & biostatistics, medical affairs, and more.